83 FR 55172 - Advisory Council for the Elimination of Tuberculosis Meeting (ACET)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 213 (November 2, 2018)

Page Range		55172-55172
FR Document		2018-23974

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 80 people and has 100 ports for audio phone lines. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is Monday, December 10, 2018. Persons who desire to make an oral statement, may request it at the time of the public comment period on December 12, 2018 at 11:40 a.m., EST.

Federal Register, Volume 83 Issue 213 (Friday, November 2, 2018)

[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Page 55172]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-23974]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis Meeting 
(ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the 
public, limited only by the space available. The meeting room 
accommodates approximately 80 people and has 100 ports for audio phone 
lines. Time will be available for public comment. The public is welcome 
to submit written comments in advance of the meeting. Comments should 
be submitted in writing by email to the contact person listed below. 
The deadline for receipt is Monday, December 10, 2018. Persons who 
desire to make an oral statement, may request it at the time of the 
public comment period on December 12, 2018 at 11:40 a.m., EST.

DATES: The meeting will be held on December 11, 2018, 8:30 a.m. to 4:30 
p.m., EST and December 12, 2018, 8:30 a.m. to 12:00 p.m., EST.

ADDRESSES: 8 Corporate Blvd., Building 8, Conference Rooms 1-A/B/C, 
Atlanta, Georgia, 30329 and Web conference: 1-877-927-1433 and 
participant passcode: 12016435 and https://adobeconnect.cdc.gov/r5p8l2tytpq/.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop: E-07, 
Atlanta, Georgia, 30333, telephone (404) 639-8317; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: This Council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.
    Matters to be Considered: The agenda will include discussions on 
(1) Division of Tuberculosis Elimination (DTBE) funded Demonstration 
Project on Latent Tuberculosis Infection (LTBI) Testing and Treatment; 
(2) DTBE Communications Messaging and Campaigns; (3) Update on LTBI 
Treatment Guidelines; (4) Update on Drug Resistant Tuberculosis 
Guidelines; and (5) Update from ACET workgroups. Agenda items are 
subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-23974 Filed 11-1-18; 8:45 am]
 BILLING CODE 4163-18-P

55172 Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices

the causes, diagnosis, treatment, control, DEPARTMENT OF HEALTH AND of Tuberculosis Elimination (DTBE)
and prevention of physical and mental HUMAN SERVICES funded Demonstration Project on Latent
diseases, and other impairments; (2) Tuberculosis Infection (LTBI) Testing
assist States and their political Centers for Disease Control and and Treatment; (2) DTBE
subdivisions in preventing and Prevention Communications Messaging and
suppressing communicable and non- Campaigns; (3) Update on LTBI
Advisory Council for the Elimination of Treatment Guidelines; (4) Update on
communicable diseases and other Tuberculosis Meeting (ACET)
preventable conditions and in Drug Resistant Tuberculosis Guidelines;
promoting health and well-being; and AGENCY: Centers for Disease Control and and (5) Update from ACET workgroups.
(3) conduct and assist in research and Prevention (CDC), Department of Health Agenda items are subject to change as
control activities related to injury. The and Human Services (HHS). priorities dictate.
Board of Scientific Counselors makes ACTION: Notice of meeting. The Chief Operating Officer, Centers
for Disease Control and Prevention, has
recommendations regarding policies, SUMMARY: In accordance with the been delegated the authority to sign
strategies, objectives, and priorities; and Federal Advisory Committee Act, the Federal Register notices pertaining to
reviews progress toward injury CDC announces the following meeting announcements of meetings and other
prevention goals and provides evidence of the Advisory Council for the committee management activities, for
in injury prevention-related research Elimination of Tuberculosis Meeting both the Centers for Disease Control and
and programs. The Board also provides (ACET). This meeting is open to the Prevention and the Agency for Toxic
advice on the appropriate balance of public, limited only by the space Substances and Disease Registry.
intramural and extramural research, the available. The meeting room
structure, progress and performance of accommodates approximately 80 people Sherri Berger,
intramural programs. The Board is and has 100 ports for audio phone lines. Chief Operating Officer, Centers for Disease
designed to provide guidance on Time will be available for public Control and Prevention.
extramural scientific program matters, comment. The public is welcome to [FR Doc. 2018–23974 Filed 11–1–18; 8:45 am]
including the: (1) Review of extramural submit written comments in advance of BILLING CODE 4163–18–P

research concepts for funding the meeting. Comments should be
opportunity announcements; (2) submitted in writing by email to the
contact person listed below. The DEPARTMENT OF HEALTH AND
conduct of Secondary Peer Review of HUMAN SERVICES
extramural research grants, cooperative deadline for receipt is Monday,
agreements, and contracts applications December 10, 2018. Persons who desire
Centers for Medicare & Medicaid
received in response to the funding to make an oral statement, may request
Services
opportunity announcements as it relates it at the time of the public comment
to the Center’s programmatic balance period on December 12, 2018 at 11:40
[CMS–3371–PN]
a.m., EST.
and mission; (3) submission of
DATES: The meeting will be held on Medicare and Medicaid Programs:
secondary review recommendations to
the Center Director of applications to be December 11, 2018, 8:30 a.m. to 4:30 Accreditation Commission for Health
p.m., EST and December 12, 2018, 8:30 Care, Inc (ACHC) for Approval of its
considered for funding support; (4)
a.m. to 12:00 p.m., EST. End Stage Renal Disease (ESRD)
review of research portfolios, and (5)
ADDRESSES: 8 Corporate Blvd., Building Facility Accreditation Program
review of program proposals.
8, Conference Rooms 1–A/B/C, Atlanta,
Matters to be Considered: The Board Georgia, 30329 and Web conference: 1– AGENCY: Centers for Medicare &
of Scientific Counselors will discuss 877–927–1433 and participant Medicaid Services (CMS), HHS.
science matters to include research passcode: 12016435 and https:// ACTION: Notice with request for
strategies needed to guide the Center’s adobeconnect.cdc.gov/r5p8l2tytpq/. comment.
focus on reducing opioid overdose and FOR FURTHER INFORMATION CONTACT:
to review the recommendations from the Margie Scott-Cseh, Committee SUMMARY: This proposed notice
opioid prescribing for acute and chronic Management Specialist, CDC, 1600 acknowledges the receipt of an
pain workgroup. Agenda items are Clifton Road, NE, Mailstop: E–07, application from the Accreditation
subject to change as priorities dictate. Atlanta, Georgia, 30333, telephone (404) Commission for Health Care, Inc., for
639–8317; zkr7@cdc.gov. recognition as a national accrediting
The Chief Operating Officer, Centers organization for End Stage Renal
for Disease Control and Prevention, has SUPPLEMENTARY INFORMATION:
Disease Facilities that wish to
been delegated the authority to sign Purpose: This Council advises and
participate in the Medicare or Medicaid
Federal Register notices pertaining to makes recommendations to the
programs.
announcements of meetings and other Secretary of Health and Human
Services, the Assistant Secretary for DATES: To be assured consideration,
committee management activities, for comments must be received at one of
Health, and the Director, CDC, regarding
both the Centers for Disease Control and the addresses provided below, no later
the elimination of tuberculosis.
Prevention and the Agency for Toxic than 5 p.m. on December 3, 2018.
Specifically, the Council makes
Substances and Disease Registry. ADDRESSES: In commenting, refer to file
recommendations regarding policies,
Sherri Berger, strategies, objectives, and priorities; code CMS–3371–PN. Because of staff
Chief Operating Officer, Centers for Disease addresses the development and and resource limitations, we cannot
Control and Prevention. application of new technologies; and accept comments by facsimile (FAX)
[FR Doc. 2018–23976 Filed 11–1–18; 8:45 am] reviews the extent to which progress has transmission.
been made toward eliminating Comments, including mass comment
BILLING CODE 4163–19–P
tuberculosis. submissions, must be submitted in one
Matters to be Considered: The agenda of the following three ways (please
will include discussions on (1) Division choose only one of the ways listed):

VerDate Sep<11>2014 17:57 Nov 01, 2018 Jkt 247001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\02NON1.SGM 02NON1

Document Created: 2018-11-02 01:09:35
Document Modified: 2018-11-02 01:09:35

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on December 11, 2018, 8:30 a.m. to 4:30 p.m., EST and December 12, 2018, 8:30 a.m. to 12:00 p.m., EST.
Contact		Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop: E-07, Atlanta, Georgia, 30333, telephone (404) 639-8317; [email protected]
FR Citation		83 FR 55172

83 FR 55172 - Advisory Council for the Elimination of Tuberculosis Meeting (ACET)

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 83, Issue 213 (November 2, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention